Navigation Links
Talecris Biotherapeutics Hires Nimish Shah as Vice President, Federal Government Relations
Date:4/29/2010

Shah will serve as a member of the federal affairs lobbying and policy team that represents Talecris to the legislative and executive branches of government in Washington, D.C.

Research Triangle Park, NC (Vocus) April 29, 2010 -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) today announced that Nimish Shah has joined the public affairs department as vice president, federal government relations.

Shah will serve as a member of the federal affairs lobbying and policy team that represents Talecris to the legislative and executive branches of government in Washington, D.C. He will collaborate with members of the public affairs team to lead Talecris’ political action committee and to educate internal and external audiences on key policy initiatives that affect Talecris’ business.

Shah brings a diverse set of skills and experience in the fields of public policy, law and business, including strategic oversight and implementation of government affairs outreach programs, regulatory and reimbursement policy development, and patient advocacy and alliance partnerships.

Before joining Talecris, Shah served as senior director and head of Takeda Pharmaceuticals’ D.C. office, where he developed and led the company’s lobbying, policy and patient advocacy functions. Prior to his position at Takeda, Shah served as director of public policy and manager of public policy and federal government affairs at Roche Pharmaceuticals. Shah spent the first twelve years of his career practicing law in Philadelphia and Washington, D.C., respectively.

Nimish earned his Bachelor of Arts degree in International Relations from Rutgers University in New Brunswick, N.J. He earned his Juris Doctor from the Rutgers School of Law and an Executive Master of Business degree from the Rutgers School of Business. He also participated in the International Law Program at Regent’s College in London, England.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.
Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com.

Contact:
Talecris Corporate Communications
Becky Levine, 919-316-6590

###

Read the full story at http://www.prweb.com/releases/Talecris_Biotherapeutics/Nimish_Shah/prweb3944394.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Northwest Biotherapeutics Inc. Appoints Market Media Connect as Communications Agency of Record
2. Integrative Logic Hires Sharon Maloney as Director of Business Intelligence
3. Linfield College's Adult Degree Program Hires New Associate Dean of Nursing for Distance Learning
4. Silverchair Learning Systems Enhances Product Expertise with New Hires
5. Stone Soup Technology Hires Former Scoop Magazine Publisher Melanie Feltman
6. The Logo Loft Hires Laid-Off Sales Executive Increasing Sales for Company by 15% Despite the Recession
7. Reliv International Hires Director of Strategic Development
8. Native Remedies and PetAlive.com Hires TransMedia Group to Herald Herbal for People and Pets
9. Aegis Health Group Hires Pearson Talbert as Chief Development Officer
10. CBCA Names Tim Reed as Vice President, Human Resources
11. Statement by Irwin Redlener, MD, President, Childrens Health Fund on Passage of a Health Care Reform Package by the House
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Talecris Biotherapeutics Hires Nimish Shah as Vice President, Federal Government Relations 
(Date:2/9/2016)... ... February 09, 2016 , ... ... LLC to help enterprises move workloads to the cloud. Cirracore provides a ... their cloud without traversing the Internet. Transformation Solutions (TSL Partners) provides a ...
(Date:2/9/2016)... ... February 09, 2016 , ... On January 12, 2016 ... an appointment after they noticed their furnace not producing any heat. Shortly after entering ... The cracked heat exchanger was leaking dangerous levels of carbon monoxide into the home, ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... service to expand access to affordable hearing aids , increase industry transparency, ... individuals in the United States. , “For the average consumer, the hearing aid ...
(Date:2/9/2016)... ... February 09, 2016 , ... United Methodist Communications collaborated ... Prevention,” an animated video designed to prevent the next widespread Ebola ... video are being distributed throughout Togo, Liberia, Sierra Leone, Nigeria, Côte d’Ivoire and ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Brain Preservation Foundation’s (BPF) ... from 21st Century Medicine (21CM) ( http://www.21cm.com/ ), spearheaded by recent MIT ... of an intact rabbit brain for extremely long-term storage using a combination of ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... 9, 2016 Mast Therapeutics, Inc. (NYSE ... sickle cell disease and heart failure, today announced that it ... purchase common stock in an underwritten public offering.  The offering ... be no assurance as to whether or when the offering ... terms of the offering.   --> ...
(Date:2/9/2016)... Feb. 9, 2016 The new report "Global Diagnostic Ultrasound ... & Consulting group reveals that global diagnostic ultrasound devices market was ... to US$ 7,466.3 million by 2019 at a CAGR of 6.8% ... global ultrasound market has been analyzed for six geographies of ... Asia-Pacific , Latin America , ...
(Date:2/9/2016)... , Feb. 9, 2016 The leader ... that AcceleDent ® is the recipient of the ... category. An FDA-cleared, Class II medical device that speeds ... percent and relieves pain often associated with treatment, AcceleDent ... participated in the annual Orthotown survey of ...
Breaking Medicine Technology: